PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer
TLX597-Tx is a PSMA [1] -targeting small molecule radioligand therapy (RLT) candidate, designed to improve quality-of-life and efficacy in earlier-stage prostate cancer. OPTIMAL-PSMA [2] initial dosimetry ...
2026-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Infinitus Presents Human Evidence-Based Research Findings at FFC 2026
GUANGZHOU, China , April 30, 2026 /PRNewswire/ -- Ma Jun, Vice President and Chief Science Innovation Officer of Infinitus (China) Company Ltd., was invited to attend the Functional Food Conference 2026 ...
2026-04-30T    Biotechnology   Food/Beverages   Health Care/Hospital 
New study demonstrates up to 73% reduction in genome analysis errors using AI-trained models versus standard approaches
SAN JOSE, Calif. , April 29, 2026 /PRNewswire/ -- Complete Genomics , a U.S.-based leader in genomic sequencing technologies, today announced results demonstrating that AI-trained variant calling ...
2026-04-29T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Navinci launches Omni kit - the next generation of spatial interactomics
UPPSALA, Sweden , April 29, 2026 /PRNewswire/ --  Navinci today announces the launch of Omni , breakthrough fully customized kits designed to transform how scientists study protein function ...
2026-04-29T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access
Contributing to the United Nations Sustainable Development Goals, driving equitable access to healthcare through technology and innovation Enhancing governance transparency and effectiveness to create ...
2026-04-29T    Environmental Products & Services   Health Care/Hospital   Medical/Pharmaceuticals 
Vivacta Bio Closed Series A and Series A+ Financing of Over US$50 Million
Backed by Decheng Capital, Loyal Valley Capital, OrbiMed, and Other Renowned Investors ...
2026-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
United Imaging Healthcare Releases 2025 Annual Report and Q1 2026 Results, Delivering Strong Growth with Accelerated Global Expansion
SHANGHAI , April 29, 2026 /PRNewswire/ -- United Imaging Healthcare (688271.SH),a global innovator in advanced medical imaging technologies and intelligent healthcare solutions, announced its 2025 annual ...
2026-04-29T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
United Imaging Healthcare Releases 2025 ESG Report: Upgraded to MSCI "AA" Rating, Driving Sustainable Development Through Innovation
SHANGHAI , April 29, 2026 /PRNewswire/ -- United Imaging Healthcare (SSE:688271) has released its 2025 Environmental, Social and Governance (ESG) Report, outlining the company's strategic framework, ...
2026-04-29T    Environmental Products & Services   Green Technology   Health Care/Hospital   Medical Equipment 
LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions
ANDERNACH, Germany , April 29, 2026 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today ...
2026-04-29T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical Equipment 
ESG | HitGen Releases 2025 Sustainability Report
CHENGDU, China , April 29, 2026 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) released its  2025 Sustainability Report on April 29, 2026. ...
2026-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.